C. Neil Lyons
Director/Board Member at Panacela Labs, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christopher Zosh | M | 48 |
Panacela Labs, Inc.
 Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 7 years |
| Leah Brownlee | F | - |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 14 years |
| Andrei V. Gudkov | M | 66 |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 21 years |
| Yakov Kogan | M | 50 |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 13 years |
| R. Elsey | M | 71 | 14 years | |
| Dmitry Lisenkov | M | 48 |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 13 years |
| Leysan Shaydullina | M | 45 |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 13 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Fonstein | M | 64 | 10 years | |
| David Christian Hohn | M | 82 | 3 years | |
| Bernard Kasten | M | 77 | 7 years | |
| Lea Verny | F | 59 | - | |
| Julia Brown | F | 76 | 2 years | |
| Pascale Sourisse | F | 61 |
SkyBridge LP
| 4 years |
| Frederick W. Schoenhut | M | 67 |
Bell Atlantic Corp.
| 4 years |
| Randy Steven Saluck | M | 59 | 3 years | |
| Langdon L. Miller | M | 70 | - | |
| Paul E. DiCorleto | M | 72 | 11 years | |
| L. Thompson Bowles | M | 92 | 8 years | |
| Ekaterina E. Nikolaevskaya | F | 62 |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 4 years |
| Anthony Principi | M | 80 | - | |
| David R. Crockford | M | 79 | - | |
| Richard McGowan | M | 70 | 2 years | |
| Anna Evdokimova | F | 49 | 6 years | |
| Elena Kasimova | F | - | - | |
| Richard J. Hindin | M | 81 | 8 years | |
| Alexey Nechaev | M | 36 | 2 years | |
| Frederic Salerno | M | 81 |
Bell Atlantic Corp.
| 4 years |
| Ivan Persiyanov | M | 44 | 4 years | |
| J. Michael Stephen | M | - |
Bell Atlantic Corp.
| 12 years |
| Debra K. Bowes | F | - | 2 years | |
| Jon Holmes | M | - |
Bell Atlantic Corp.
| 2 years |
| Yulia Lebedina | F | 45 | 1 years | |
| Natalia Saraeva | F | - | - | |
| Tatiana Levina | F | - | - | |
| Roberta Alford | F | - |
Bell Atlantic Corp.
| - |
| Konstantin Gorshkov | M | - | - | |
| Gillian Miller | M | - | - | |
| Judith Schnyder | F | - | - | |
| Natalia Khudyk | F | - | - | |
| Duane W. Albro | M | 77 |
Bell Atlantic Corp.
| 3 years |
| Alexander Polinsky | M | 67 | - | |
| Walter A. Meffert | M | 59 |
Bell Atlantic Corp.
| 1 years |
| Elizabeth T. Kennan | M | 85 |
Bell Atlantic Corp.
| 3 years |
| Carolyn S. Burger | F | 83 |
Bell Atlantic Corp.
| 5 years |
| Wayne A. Budd | M | 82 |
Bell Atlantic Corp.
| 4 years |
| Len J. Lauer | M | 67 |
Bell Atlantic Corp.
| 6 years |
| Julie Dobson | F | 67 |
Bell Atlantic Corp.
| 1 years |
| William O. Albertini | M | 80 |
Bell Atlantic Corp.
| 2 years |
| Daniel F. Hoth | M | 78 | 1 years | |
| Dane Saglio | M | 66 | 3 years | |
| George J. Parise | M | - |
Bell Atlantic Corp.
| 3 years |
| Nabila Turjman | M | - | - | |
| Douglas R. Wilburne | M | - |
Bell Atlantic Corp.
| - |
| Celia M. Stokes | F | 60 |
Bell Atlantic Corp.
| 5 years |
| Charles E. Kirkpatrick | M | - |
Bell Atlantic Corp.
| 1 years |
| Douglas J. Mello | M | 81 |
Bell Atlantic Corp.
| 3 years |
| Jean Viallet | M | 66 | 1 years | |
| Craig Collins | M | 60 |
Bell Atlantic Corp.
| 4 years |
| James Mendolera | M | - | 9 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 59 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- C. Neil Lyons
- Personal Network
